Prakash

Author's details

Name: Prakash Nallathamby
Date registered: July 27, 2017

Latest posts

Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) — August 30, 2024
Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa — August 21, 2024
Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) — June 19, 2024
MTEC Annual meeting in Baltimore MD (May 24, 2024) — May 24, 2024
Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 — May 7, 2024

Author's posts listings

May 14

Nallathamby Lab Presents Novel Antibacterial and Novel Chemotherapeutics Work at MRS 2022 Spring Meeting (May 8-13, 2022| Honolulu, Hawai’i)

Categories:

antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Conference abstracts

by Prakash

Our research looks at the basic mechanism of drug resistance in bacteria or cancer cells and then we work on translational solutions to combat these problems. Our approach felt validated at this meeting where we networked with industry end-users as well as disease-on-a chip modeling academicians.

Tags: antibacterial, biomimetic, cancer therapy, chemoresistant, MRS Spring 2022, multidrug resistance

Jan 09

Nallathamby Lab at the Society for Biomaterials/ Japanese Society for Biomaterials (Jan 8-10, 2022) Hawaii

Categories:

antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Label-free, magnetoelectrics

by Prakash

Virtually presented our lab’s research on tackling two pressing problems in biomedical research at the Society for Biomaterials/ Japanese Society for Biomaterials joint Symposium in Honolulu, Hawaii. (January 8-10, 2022). I am presenting our research on broad-spectrum antibiotic-free antibacterials to combat multi-drug resistant bacterial infections. Oral Presentation Session: Session 1: Bioglasses/Ceramics/Other Hard Materials2:37 – 2:52 …

This post has no tag

Sep 02

Excited to be Funded by the Institute for Precision Health’s Harvest Grant

Categories:

antibiotics, Antimicrobial, Berthiaume Institute for Precision Health

by Prakash

The University of Notre Dame’s Institute for Precision Health (IPH) has awarded funding to researchers spanning multiple departments at the University, as well as to colleagues at partner schools. IPH awarded proposals with two types of funding: seed grants, which provide funding for high-risk, high-reward research ideas, and harvest grants, which help researchers expand on established projects or pursue …

Tags: Berthiaume Institute for Precision Health

Jun 20

ACS-Institutional Research Grant -Phase II Grant Funded to Mitigate Cardiotoxicity of Chemotherapeutics using our Nanocarriers

Categories:

American Cancer Society, Berthiaume Institute for Precision Health, Label-free, magnetoelectrics

by Prakash

Excited that our phase-II proposal to the American Cancer Society’s Institutional Research Grant (ACS-IRG) program was funded. This was upon successful phase I completion of our proposal for a novel magnetically driven drug nanocarrier. We propose to use these drug nanocarriers to mitigate cardiotoxicity in the new study. The data generated by the study funded …

This post has no tag

Sep 26

RIDING TO FIGHT KIDS’ CANCER

Categories:

Berthiaume Institute for Precision Health, Fund raising, Pediatric Cancer

by Prakash

This September, I am taking part in the Great Cycle Challenge to fight kids’ cancer! Only 4% of the billions of dollars the government spends annually on cancer research is directed towards treating childhood cancer. Right now, cancer is the biggest killer of children from disease in the United States. Over 15,700 children are diagnosed …

Tags: advanceddignosticstherapeutics, fightingirishfightingcancer, fightingkidscancer, greattcyclechallenge

Mar 01

Science Outlets are More Actively Promoting Novel Technologies to Address Antibiotic-Resistant Bacteria and Antibiotic-Stewardship

Categories:

AD&T Notre Dame, antibiotics, Antimicrobial, Berthiaume Institute for Precision Health

by Prakash

Excited that our novel approach to tackling antibiotic resistance is gaining well-deserved publicity! We need outside the box thinking to tackle this problem. Juliane Hopf #advanceddoagnosticsandtherapeutics #notredame #antibioticresistance #nanotechnology #nanoscaleadvances #pdnano #biomimetics #health #nanoparticles #nd https://phys.org/news/2020-01-tackling-antibiotic-resistance-phage-mimicking-antibacterial.html Tackling antibiotic resistance: Phage-mimicking antibacterial core-shell nanoparticles could help by Brandi Wampler, University of Notre Dame Nanoparticle. Credit: P Nallathamby …

This post has no tag

Jan 24

An Interesting Write-up on our Novel Class of Antibacterials to Tackle Antibiotic Resistant Pathogens

Categories:

AD&T Notre Dame, antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, multidrug resistance

by Prakash

According to the World Health Organization, one of the biggest health threats around the world is antibiotic-resistant bacteria. Researchers at Notre Dame are working to combat this problem by developing a nanoparticle-based system. Please check out this press release written by Brandi Wampler, our science communication specialist at Notre Dame Research. https://news.nd.edu/news/new-technology-could-help-tackle-antibiotic-resistance/ The peer-reviewed publication …

Tags: #antibioticsresistant, #biomimetic, #MRSA, #multidrugresistanc, #nallathambylab, #pseudomonas

Nov 08

Fighting antibiotic resistant bacteria by skipping anitbiotics

Categories:

antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, multidrug resistance

by Prakash

Phage-mimicking antibacterial core–shell nanoparticles. Excited to have started publishing and filing for a patent on our antibiotic-free antimicrobial nanoparticles research. More to come in the following months! Thankful for the support from #notredame #ideacenter #antibioticresistance #ndnano #Advanceddiagnosticsandtherapeutics #ADandT #openaccess The increasing frequency of nosocomial infections caused by antibiotic-resistant microorganisms concurrent with the stagnant discovery of …

This post has no tag

Aug 12

Real Men Wear Pink of Michiana

Categories:

American Cancer Society, Berthiaume Institute for Precision Health, Fund raising, Harper Cancer Research Institute

by Prakash

Here is my fundraising profile for the local chapter of the American Cancer Society. https://www.facebook.com/MichianaRMWP/posts/1321606701327331

This post has no tag

Aug 08

Real Men Wear Pink in Michiana to Fight Breast Cancer

Categories:

AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health

by Prakash

DONATE to ACS Online Why We Wear Pink. Breast cancer affects everyone – it doesn’t matter if you’re a man or a woman. That’s why I’m stepping up to fight breast cancer with all I have. Since I’m in a position to make a difference within my community, I believe I have an obligation …

Tags: breastcancer, breastcancerawareness, michiana, NDNano, realmenwearpink

NIH Funding Opportunities

NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) November 21, 2024
Funding Opportunity RFA-NR-25-002 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications from multidisciplinary teams of experts in firearm injury prevention research across departments and institutions to develop and provide research resources and support to build capacity among United States (U.S.) nurse researchers for rigorous, high-impact research in […]
Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional) November 21, 2024
Funding Opportunity RFA-DA-26-017 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research and development of medical devices specifically indicated for pediatric population (i.e., 0-21 years old, as defined by the FDA Center for Devices and […]
Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional) November 21, 2024
Funding Opportunity RFA-DA-26-016 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research and development of medical devices specifically indicated for pediatric population (i.e., 0-21 years old, as defined by the FDA Center for Devices and […]
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) November 21, 2024
Funding Opportunity PAR-25-261 from the NIH Guide for Grants and Contracts. The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. […]
Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed) November 21, 2024
Funding Opportunity RFA-MH-26-111 from the NIH Guide for Grants and Contracts. Eradicating latent reservoirs of HIV-1 within the body and achieving a sterilizing or functional cure have become priority areas in the AIDS field and NIH AIDS programs across many Institutes and Centers, including NIMH. In addition understanding the mechanisms of HIV- associated co-morbidities in […]
Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed) November 21, 2024
Funding Opportunity RFA-MH-26-110 from the NIH Guide for Grants and Contracts. Eradicating latent reservoirs of HIV-1 within the body and achieving a sterilizing or functional cure have become priority areas in the AIDS field and NIH AIDS programs across many Institutes and Centers, including NIMH. In addition understanding the mechanisms of HIV- associated co-morbidities in […]
Notice of Early Expiration of PAR-22-138, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" November 21, 2024
Notice NOT-MH-25-076 from the NIH Guide for Grants and Contracts
Notice of Early Expiration of PAR-22-137, Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) November 21, 2024
Notice NOT-MH-25-075 from the NIH Guide for Grants and Contracts
Notice of Early Expiration of "Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine", NOT-AI-22-013 November 21, 2024
Notice NOT-AI-24-084 from the NIH Guide for Grants and Contracts
Webinar for Notice of Special Interest (NOSI): Training Modules for Enhancing Biomedical Research Workforce Training November 21, 2024
Notice NOT-GM-25-009 from the NIH Guide for Grants and Contracts

Nallathamby Laboratory

Modular and scalable nanotechnology for imaging, sensing and therapeutics

Prakash

Author's details

Latest posts

Author's posts listings

Nallathamby Lab Presents Novel Antibacterial and Novel Chemotherapeutics Work at MRS 2022 Spring Meeting (May 8-13, 2022| Honolulu, Hawai’i)

Nallathamby Lab at the Society for Biomaterials/ Japanese Society for Biomaterials (Jan 8-10, 2022) Hawaii

Excited to be Funded by the Institute for Precision Health’s Harvest Grant

ACS-Institutional Research Grant -Phase II Grant Funded to Mitigate Cardiotoxicity of Chemotherapeutics using our Nanocarriers

RIDING TO FIGHT KIDS’ CANCER

Science Outlets are More Actively Promoting Novel Technologies to Address Antibiotic-Resistant Bacteria and Antibiotic-Stewardship

An Interesting Write-up on our Novel Class of Antibacterials to Tackle Antibiotic Resistant Pathogens

Fighting antibiotic resistant bacteria by skipping anitbiotics

Real Men Wear Pink of Michiana

Real Men Wear Pink in Michiana to Fight Breast Cancer

Recent Posts

Recent Comments

Archives

Categories

Meta

NIH Funding Opportunities

Copyright